REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,524,088 | +113.4% | 271,824 | +106.2% | 0.01% | +125.0% |
| Q2 2023 | $3,525,971 | +21.0% | 131,812 | -2.0% | 0.00% | 0.0% |
| Q1 2023 | $2,913,530 | +29.9% | 134,512 | +42.8% | 0.00% | +33.3% |
| Q4 2022 | $2,243,201 | +21.8% | 94,173 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $1,841,000 | +17.6% | 94,173 | +17.3% | 0.00% | 0.0% |
| Q2 2022 | $1,565,000 | -30.6% | 80,297 | -9.2% | 0.00% | 0.0% |
| Q1 2022 | $2,255,000 | +22.8% | 88,400 | +21.1% | 0.00% | 0.0% |
| Q4 2021 | $1,837,000 | -8.5% | 73,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,008,000 | +147.0% | 73,000 | +157.0% | 0.00% | +100.0% |
| Q2 2021 | $813,000 | +174.7% | 28,400 | +203.1% | 0.00% | – |
| Q2 2020 | $296,000 | +44.4% | 9,370 | 0.0% | 0.00% | – |
| Q1 2020 | $205,000 | – | 9,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |